Back

Challenges and opportunities in drug development for inherited cardiac diseases

6 December 2025 (08:30 - 08:40)
Organised by: Logo
Seminar Presentation Part of: Session 8 – Challenges in trial design and drug approval Endorsed by ERN Guard Heart OTHER Open Access ESC Cardio Genomics 2025 Council on Cardiovascular Genomics

About the speaker

Photo
Professor Perry Mark Elliott

University College London, London (United Kingdom of Great Britain & Northern Ireland)

2 More presentations in this session

Presentation thumbnail
Value of patient registries and real word data for clinical trials in inherited cardiac diseases
Professor S. Kaab (Munich, DE)
Presentation thumbnail
Translational breakthroughs and new therapies for inherited cardiac diseases
Professor Y. Pinto (Amsterdam, NL)

Access the full session

Session thumbnail
Session 8 – Challenges in trial design and drug approval Endorsed by ERN Guard Heart

The Event

Event poster

ESC Cardio Genomics 2025

6 December 2025 08:30 CET
You may be interested in
thumbnail
Congress Session
Genetics in heart failure
18 May 2025
thumbnail
Congress Session
New insights into cancer therapy-related cardiac dysfunction
18 May 2025
thumbnail
Congress Presentation
Mid-term benefit of pharmacological chaperone therapy on cardiac manifestation in Japanese Fabry disease
29 August 2025
thumbnail
Congress Session
Hottest trials and trial updates (2)
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources